SRT3109
Product Specifications
UNSPSC Description
SRT3109 is an antagonist of CXCR2, with a pIC50 of 8.2, and used in the research of chemokine mediated diseases.
Target Antigen
CXCR
Type
Reference compound
Related Pathways
GPCR/G Protein;Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Endocrinology
Assay Protocol
https://www.medchemexpress.com/srt3109.html
Solubility
DMSO : ≥ 100 mg/mL
Smiles
FC1=C(F)C=CC=C1CSC2=NC(NS(=O)(N3CCC3)=O)=CC(N[C@@H]([C@@H](O)CO)C)=N2
Molecular Weight
475.53
References & Citations
[1]Premji Meghani, et al. Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases. WO2010007427A1
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-15462/SRT3109-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-15462/SRT3109-SDS-MedChemExpress.pdf
Clinical Information
Phase 1
CAS Number
1204707-71-0
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Rabbit Tumor Necrosis Factor Ligand Superfamily, Member 9 ELISA Kit
Recombinant Yersinia pseudotuberculosis Imidazole glycerol phosphate synthase subunit HisH (hisH)
Recombinant Yersinia pseudotuberculosis Imidazole glycerol phosphate synthase subunit HisH (hisH)
Recombinant Yersinia pseudotuberculosis Imidazole glycerol phosphate synthase subunit HisH (hisH)
